StonvexLoading…
StonvexStonvexStonvexCore line items from BNBX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $2.14M | $2.11M | $13.37M | $18.17M |
Operating Income | $-16.05M | $-13.67M | $-10.95M | $-13.97M |
Net Income | $-15.16M | $-6.99M | $-9.95M | $-8.27M |
EPS (Diluted) | $-134.23 | $-1366.42 | $-15.21 | $-0.93 |
Total Assets | $4.44M | $12.79M | $13.65M | $22.27M |
Total Liabilities | $2.50M | $3.82M | $8.78M | $9.36M |
Cash & Equivalents | $1.67M | $5.85M | $7.15M | $15.22M |
Free Cash Flow OCF − CapEx | $-12.56M | $-14.12M | $-6.30M | $-9.47M |
Shares Outstanding | 1.66M | 13.76K | 682.93K | 12.91M |